Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Restrepo, Blanca I ^a   Twahirwa, Marcel ^b   Rahbar, Mohammad H ^c   Schlesinger, Larry S ^d  

^a School of Public Health at Brownsville   (United States)

^b Doctors Hospital at Renaissance   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; OPSONIN; COMPLEMENT RECEPTOR;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERGLYCEMIA; MALE; MONOCYTE; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHAGOCYTOSIS; SHEEP; ANIMAL; CHRONIC DISEASE; COMPLICATION; FLUORESCENCE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE;

ADULT; ANIMALS; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MONOCYTES; PHAGOCYTOSIS; PHENOTYPE; RECEPTORS, COMPLEMENT; RECEPTORS, IGG; SHEEP;

EID: 84899786502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092977     Document Type: Article

References (42)

1. Peleg AY, Weerarathna T, McCarthy JS, Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23: 3-13. (Pubitemid 46152480)
2. Zumla A, Raviglione M, Hafner R, von Reyn CF (2013) Tuberculosis. N Engl J Med 368: 745-755.
3. World Health Organization (2013) Global tuberculosis report 2013. Available: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656-eng. pdf.
4. Restrepo BI, Camerlin A, Rahbar M, Restrepo M, Zarate I, et al. (2011) Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis patients. Bull World Health Organ 89: 352-359.
5. Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5: 1091-1101.
6. Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, et al. (2007) Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 3: 228-245. (Pubitemid 351927860)
7. Harries AD, Lin Y, Satyanarayana S, Lonnroth K, Li L, et al. (2011) The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 15: 1436-1445.
8. Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI (2013) Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis 93: 192-197.
9. Restrepo BI, Fisher-Hoch S, Pino P, Salinas A, Rahbar MH, et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634-641.
10. Walsh M, Camerlin A, Miles R, Pino P, Martinez P, et al. (2010) Sensitivity of Interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis 15: 179-184.
11. Stalenhoef JE, Alisjahbana B, Nelwan EJ, van d, V, Ottenhoff TH, et al. (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27: 97-103.
12. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis Susceptibility of Diabetic Mice. Am J Respir Cell Mol Biol 37: 518-524. (Pubitemid 350058182)
13. Vallerskog T, Martens GW, Kornfeld H (2010) Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 184: 6275-6282.
14. Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93: S10-S14.
15. Guirado E, Schlesinger LS, Kaplan G (2013) Macrophages in tuberculosis: friend or foe. Semin Immunopathol 35: 563-583.
16. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA (1990) Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 144: 2771-2780. (Pubitemid 20136689)
17. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, et al. (2011) Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 3: 104ra102.
18. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9: 81.
19. Horwitz MA, Silverstein SC (1980) Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest 65: 82-94. (Pubitemid 10214334)
20. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. (Pubitemid 41746764)
21. American Diabetes Association (2010) Standards of Medical Care in Diabetes-2010. Diabetes Care 33: S11-S61.
22. Serbina NV, Jia T, Hohl TM, Pamer EG (2008) Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 26: 421-452. (Pubitemid 351600381)
23. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23: 2053-2058. (Pubitemid 23265862)
24. Tridandapani S, Siefker K, Teillaud JL, Carter JE, Wewers MD, et al. (2002) Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells. J Biol Chem 277: 5082-5089. (Pubitemid 34968549)
25. Geisler C, Almdal T, Bennedsen J, Rhodes JM, Kolendorf K (1982) Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand [C] 90: 33-7. (Pubitemid 12177110)
26. Katz S, Klein B, Elian I, Fishman P, Djaldetti M (1983) Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6: 479-82. (Pubitemid 13005557)
27. Liu BF, Miyata S, Kojima H, Uriuhara A, Kusunoki H, et al. (1999) Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 48: 2074-2082. (Pubitemid 29458374)
28. Schlesinger LS (1996) Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Curr Top Microbiol Immunol 215: 71-96.
29. Underhill DM, Goodridge HS (2012) Information processing during phagocytosis. Nat Rev Immunol 12: 492-502.
30. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, et al. (2005) The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202: 987-999. (Pubitemid 41396898)
31. Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, et al. (2010) Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol 185: 929-942.
32. Cooper NR (1991) Complement evasion strategies of microorganisms. Immunol Today 12: 327-331.
33. Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS (2013) Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog 9: e1003114.
34. Hodgson KA, Morris JL, Feterl ML, Govan BL, Ketheesan N (2011) Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect 13: 1177-1184.
35. Chang FY, Shaio MF (1995) Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28: 137-46.
36. Loike JD, Kozler VF, Silverstein SC (1979) Increased ATP and creatine phosphate turnover in phagocytosing mouse peritoneal macrophages. J Biol Chem 254: 9558-9564. (Pubitemid 10248720)
37. Hair PS, Echague CG, Rohn RD, Krishna NK, Nyalwidhe JO, et al. (2012) Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med 10: 35.
38. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, et al. (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
39. Labuzek K, Liber S, Gabryel B, Adamczyk J, Okopien B (2010) Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol 381: 171-186.
40. Mathews CE, Brown EL, Martinez PJ, Bagaria U, Nahm M, et al. (2012) Impaired function of antibodies to Pneumococcal surface protein A and not to Capsular Polysaccharide in Mexican American Adults with Type 2 Diabetes Mellitus. Clin Vaccine Immunol 19: 1360-1369.
41. Dandona P, Chaudhuri A, Mohanty P, Ghanim H (2007) Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 10: 511-517. (Pubitemid 46934123)
42. Feng B, Xu L, Wang H, Yan X, Xue J, et al. (2011) Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. Biochim Biophys Acta 1812: 1130-1137.